Treatment of Cervical Dystonia
Botulinum toxin type A injections are the first-line treatment for cervical dystonia, with recommended doses of 120-240 units for incobotulinumtoxinA (Xeomin) administered every 12 weeks. 1
First-Line Treatment: Botulinum Toxin
Botulinum Toxin Formulations
- OnabotulinumtoxinA (Botox): 135 units recommended, not exceeding 400 units every 84 days 2
- IncobotulinumtoxinA (Xeomin): 120-240 units per treatment 1
- AbobotulinumtoxinA (Dysport): Starting dose of 500 units recommended 2, 3
- RimabotulinumtoxinB (Myobloc): Alternative formulation with similar efficacy 2
Injection Technique
- Target the most affected muscles based on the pattern of dystonia
- Common injection sites include:
- Sternocleidomastoid (median 25 units of Xeomin)
- Splenius capitis/semispinalis (median 48 units of Xeomin)
- Trapezius (median 25 units of Xeomin)
- Levator scapulae (median 25 units of Xeomin)
- Scalene muscles (median 20 units of Xeomin) 1
- EMG guidance is recommended for more precise injections and better outcomes 4
Dosing Considerations
- Start with lower doses (e.g., 120 units of Xeomin or 500 units of Dysport) and titrate upward in subsequent sessions if needed 1, 3
- While standard injection intervals are ≥12 weeks, approximately 47% of patients may require reinjection at ≤12 weeks 5
- Use the lowest effective dose at the longest possible interval to maintain responsiveness over time 4
Second-Line and Adjunctive Treatments
Oral Medications
- Nerve-stabilizing agents:
- Pregabalin
- Gabapentin
- Duloxetine 2
- Sodium channel blockers:
- Carbamazepine (50-200 mg/day)
- Oxcarbazepine (75-300 mg/day) 2
Rehabilitation Approaches
- Referral to rehabilitation specialists for comprehensive neuromusculoskeletal management
- Manual treatment including mobilization and manipulation of cervical and thoracic spine
- Vestibular rehabilitation if vestibular symptoms are present 2
Follow-up and Monitoring
- Reassess within 1 month after initial treatment to evaluate:
- Symptom resolution
- Side effects
- Need for dose adjustment 2
- Monitor for potential side effects:
- Dysphagia (difficulty swallowing)
- Neck weakness
- Voice changes
- In rare cases, respiratory difficulties 1
Important Considerations and Precautions
Potential Side Effects
- Dysphagia occurs more frequently with bilateral sternocleidomastoid injections
- Patients with smaller neck muscle mass may be at greater risk for side effects
- Limiting the dose injected into the sternocleidomastoid muscle may decrease dysphagia risk 1
Treatment Failures
- If inadequate response, consider:
- Adjusting dose
- Modifying injection sites
- Switching to another botulinum toxin serotype 2
Contraindications
- Known hypersensitivity to botulinum toxin or excipients
- Caution in patients with pre-existing swallowing or breathing difficulties
- Caution in patients with neuromuscular junction disorders (e.g., myasthenia gravis) 1